Table 3.
Variables associated with strain in the patient group; univariate and multivariable analyses.
| Univariate analysisb | Multivariable analysisc | ||||
|---|---|---|---|---|---|
| Variable | N | Mean ± SD or β (SE) | P | Adjusted mean (SE) or β (SE) | P |
| Age (years) | 90 | −0.086 (0.058) | 0.143 | 0.043 (0.094) | 0.646 |
| Sex (m/f) | 0.031* | 0.020* | |||
| Male | 41 | 21.46 ± 2.59 | 21.89 (0.75) | ||
| Female | 49 | 20.21 ± 2.78 | 20.56 (0.72) | ||
| BMI, kg/m2 | 90 | −0.151 (0.071) | 0.036* | −0.215 (0.068) | 0.002* |
| Follow-up time (years) | 90 | −0.106 (0.048) | 0.029* | −0.199 (0.088) | 0.027* |
| Cardiac risk group | 0.491 | 0.222 | |||
| No risk | 5 | 21.68 ± 2.48 | 23.83 (1.83) | ||
| Low | 4 | 19.70 ± 3.39 | 20.48 (1.41) | ||
| Intermediate | 47 | 21.08 ± 2.94 | 20.94 (0.51) | ||
| High | 34 | 20.37 ± 2.46 | 19.64 (0.64) | ||
| Cumulative anthracycline dose,a mg/m2 | 90 | −0.001 (0.003) | 0.727 | 0.002 (0.005) | 0.619 |
| Chest radiotherapy | 0.004* | 0.370 | |||
| No | 70 | 21.22 ± 2.50 | 21.57 (0.59) | ||
| Yes | 20 | 19.26 ± 3.11 | 20.87 (0.93) | ||
| Hypertension | 0.291 | 0.527 | |||
| Normal | 63 | 20.96 ± 2.91 | 21.43 (0.70) | ||
| High | 26 | 20.27 ± 2.33 | 21.03 (0.78) | ||
Indicates statistically significant.
β indicates regression coefficient for one-unit increase in continuous variables.
Doxorubicin isotoxic equivalents.
The means between two groups were compared with the independent samples t-test and between cardiac risk groups with the one-way ANOVA.
Linear regression was used to evaluate the association of continuous variable with strain.
Multivariable linear model.